Insider: ROSEN TERRY J Chief Executive Officer - Arcus Biosciences, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,554,160 | 3,231,179 | 5,785,339 |
| Value | $32,795,414.40 | $41,488,338.36 | $74,283,752.76 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/27/2025 | AAP | 19,800 | Direct | COM | $10.18 | $201,465.00 | 2,554,160 |
| 12/16/2022 | DDS | 10,983 | Direct | COM | $30.66 | $336,738.78 | 244,233 |
| 12/16/2022 | DDS | 2,060 | Direct | COM | $31.23 | $64,333.80 | 242,173 |
| 06/17/2022 | DDS | 1,361 | Direct | COM | $21.71 | $29,547.31 | 230,968 |
| 06/17/2022 | DDS | 3,252 | Direct | COM | $22.29 | $72,487.08 | 227,716 |
| 06/16/2022 | DDS | 4,241 | Direct | COM | $20.72 | $87,873.52 | 232,329 |
| 12/17/2021 | DDS | 653 | Direct | COM | $38.79 | $25,328.37 | 213,860 |
| 12/17/2021 | DDS | 417 | Direct | COM | $39.67 | $16,543.18 | 213,443 |
| 12/17/2021 | DDS | 808 | Direct | COM | $40.57 | $32,783.15 | 212,635 |
| 12/17/2021 | DDS | 1,065 | Direct | COM | $41.42 | $44,116.35 | 211,570 |
| 12/16/2021 | DDS | 1,680 | Direct | COM | $39.59 | $66,513.89 | 215,132 |
| 12/16/2021 | DDS | 619 | Direct | COM | $40.46 | $25,042.57 | 214,513 |
| 06/17/2021 | DDS | 4,863 | Direct | COM | $23.68 | $115,155.84 | 205,562 |
| 06/16/2021 | DDS | 3,809 | Direct | COM | $24.13 | $91,911.17 | 210,584 |
| 06/16/2021 | DDS | 159 | Direct | COM | $24.77 | $3,938.43 | 210,425 |
| 08/10/2020 | AAP | 32,050 | Indirect | COM | $23.38 | $749,402.72 | 3,231,179 |
| 08/07/2020 | AAP | 11,655 | Indirect | COM | $21.44 | $249,911.17 | 3,199,129 |
| 06/06/2019 | AAP | 2,380 | Indirect | COM | $7.95 | $18,928.14 | 3,023,139 |
| 06/05/2019 | AAP | 19,358 | Indirect | COM | $7.93 | $153,416.02 | 3,020,759 |
| 06/04/2019 | AAP | 25,770 | Indirect | COM | $7.75 | $199,825.73 | 3,001,401 |
| 06/03/2019 | AAP | 15,770 | Indirect | COM | $8.16 | $128,749.43 | 2,975,631 |
| 08/28/2018 | AAP | 10,650 | Indirect | COM | $15.48 | $164,844.96 | 3,959,861 |
| 08/27/2018 | AAP | 7,157 | Indirect | COM | $14.48 | $103,649.11 | 3,948,411 |
| 08/27/2018 | AAP | 800 | Indirect | COM | $14.92 | $11,937.04 | 3,949,211 |
| 08/24/2018 | AAP | 4,954 | Indirect | COM | $13.40 | $66,363.29 | 3,941,254 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research